Search Within

David Hyman

  1. "Ryma Benayed"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (14)
Groups
  1. Department of Medicine (36)
  2. Early Drug Development Service (36)
  3. GSK Faculty (36)
  4. Solid Tumor Oncology Division (36)
  5. Department of Pathology and Laboratory Medicine (34)
  6. Tow Center for Developmental Oncology (TCDO) (32)

More Groups

People
  1. Ryma Benayed (36)
  2. Marc Ladanyi (30)
  3. Alexander Drilon (22)
  4. Ahmet Zehir (21)
  5. Jaclyn Hechtman (21)
  6. Maria Arcila (18)

More People

Years
  1. 2021 (1)
  2. 2020 (8)
  3. 2019 (7)
  4. 2018 (8)
  5. 2017 (10)
  6. 2016 (1)

More Years

Publications
  1. Cancer Discovery (4)
  2. American Journal of Surgical Pathology (3)
  3. Cancer Research (3)
  4. Clinical Cancer Research (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Molecular Diagnostics (3)

More Publications

Publishers
  1. American Association for Cancer Research (11)
  2. American Society of Clinical Oncology (5)
  3. Nature Publishing Group (4)
  4. Elsevier Science, Inc. (3)
  5. Lippincott Williams & Wilkins (3)
  6. Nature Research (3)

More Publishers

Results (36)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation
    Journal Article

    Selenica, P.; Conlon, N.; Gonzalez, C.; Frosina, D.; Jungbluth, A. A.; Beets-Tan, R. G. H.; Rao, M. K.; Zhang, Y.; Benayed, R.; Ladanyi, M.; more...
    American Journal of Surgical Pathology (2021)

    Fulltext@MSK | Save
  • Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Meeting Abstract

    Liu, B.; Ross, D. S.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Cancer therapy shapes the fitness landscape of clonal hematopoiesis
    Journal Article

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Kelly, D.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; more...
    Nature Genetics (2020)

    Fulltext@MSK | Save
  • Enrichment of kinase fusions in ESR1 wild-type, metastatic breast cancer revealed by a systematic analysis of 4854 patients
    Journal Article

    Ross, D. S.; Liu, B.; Schram, A. M.; Razavi, P.; Lagana, S. M.; Zhang, Y.; Scaltriti, M.; Bromberg, J. F.; Ladanyi, M.; Hyman, D. M.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Landscape and outcome of TRK fusion-positive cancers
    Meeting Abstract

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • TRK fusions are enriched in cancers with uncommon histologies and the absence of canonical driver mutations
    Journal Article

    Rosen, E. Y.; Goldman, D. A.; Hechtman, J. F.; Benayed, R.; Schram, A. M.; Cocco, E.; Shifman, S.; Gong, Y.; Kundra, R.; Solomon, J. P.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Detection of RET kinase fusions using DNA, RNA, and protein-based methods
    Meeting Abstract

    Yang, S. R.; Mata, D.; Benayed, R.; Mullaney, K.; Frosina, D.; Rekhtman, N.; Drilon, A.; Hyman, D.; Ladanyi, M.; Jungbluth, A.; more...
    Laboratory Investigation (2020)

    Fulltext@MSK | Save
  • NTRK fusion detection across multiple assays and 33,997 cases: Diagnostic implications and pitfalls
    Journal Article

    Solomon, J. P.; Linkov, I.; Rosado, A.; Mullaney, K.; Rosen, E. Y.; Frosina, D.; Jungbluth, A. A.; Zehir, A.; Benayed, R.; Drilon, A.; more...
    Modern Pathology (2020)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save